BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CEL-SCI Corporation 

8229 Boone Boulevard
Suite 802
Vienna  Virginia  22182  U.S.A.
Phone: 703-506-9460 Fax: 703-506-9471


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
CEL-SCI (CVM) Receives Regulatory Clearance To Expand Its Phase 3 Head And Neck Cancer Trial Into Romania 1/26/2015 8:30:32 AM
CEL-SCI (CVM) To Present At Biotech Showcase 2015 1/9/2015 9:34:41 AM
Date Set For Arbitration Trial Between CEL-SCI (CVM) And Clinical Research Organization inVentiv Clinical 1/6/2015 11:13:38 AM
CEL-SCI (CVM)’s 2014 Patient Enrollment Increases Eight-Fold Over 2013 In Its Phase 3 Head And Neck Cancer Trial 1/5/2015 10:23:18 AM
CEL-SCI (CVM) Reports Fiscal 2014 Financial Results And Clinical & Corporate Developments 12/29/2014 9:57:52 AM
CEL-SCI (CVM) Reports Fiscal 2014 Financial Results And Clinical & Corporate Developments 12/24/2014 7:35:41 AM
CEL-SCI (CVM) Expands Its Pivotal Phase 3 Immunotherapy Head And Neck Cancer Trial With Addition Of 7 More Clinical Sites 12/8/2014 10:47:18 AM
CEL-SCI (CVM) Quarterly Patient Enrollment In Its Head And Neck Cancer Phase 3 Trial Increases Eight Fold Over Same Prior Year Period 12/2/2014 9:47:36 AM
CEL-SCI (CVM) Enrolls 22 Patients During October In Its Phase 3 Immunotherapy Head And Neck Cancer Trial 11/3/2014 10:39:15 AM
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $6 Million 10/24/2014 10:54:31 AM
12345678910...